THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
161,086,122
Share change
+3,177,670
Total reported value
$195,000,979
Put/Call ratio
192%
Price per share
$1.21
Number of holders
150
Value change
+$2,870,955
Number of buys
68
Number of sells
50

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2020

As of 31 Dec 2020, THERAPEUTICSMD INC - COM (TXMD) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 161,086,122 shares. The largest 10 holders included BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, VANGUARD GROUP INC, MORGAN STANLEY, RA CAPITAL MANAGEMENT, L.P., C WorldWide Group Holding A/S, GMT CAPITAL CORP, AMERIPRISE FINANCIAL INC, and Rubric Capital Management LP. This page lists 150 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.